miR-34a plays pro-apoptotic and pro-senescence roles in mesenchymal stem cell by targeting SIRT1; furthermore, inhibition of miR-34a might have important therapeutic implications in MSC-based therapy for myocardial infarction [28]. The gene discussed is SIRT1; the disease is myocardial infarction.